References
[1] Cornelissen AWCA, Schetters TPM. Vaccines against protozoal diseases of veterinary importance. FEMS Immunol Med Microbiol. 1996;15(2-3):61-72. doi:10.1111/j.1574-695X.1996.tb00055.x.
[2] Dumonteil E. DNA Vaccines against Protozoan Parasites: Advances and Challenges. J Biomed Biotechnol. 2007;2007:90520. doi:10.1155/2007/90520.
[3] Goodswen SJ, Kennedy PJ, Ellis JT. A state-of-the-art methodology for high-throughput in silico vaccine discovery against protozoan parasites and exemplified with discovered candidates for Toxoplasma gondii. Sci Rep. 2023;13(1):8243. doi:10.1038/s41598-023-34863-9.
[4] Hashim O, Dimier-Poisson I. Computational vaccine development against protozoa. Comput Struct Biotechnol J. 2025;27:2386-2393. doi:10.1016/j.csbj.2025.06.011.
[5] Martiniano De Pádua JA, Ribeiro D, De Aguilar VFF, et al. Overview of Commercial Vaccines Against Canine Visceral Leishmaniasis: Current Landscape and Future Directions. Pathogens. 2025;14(10):970. doi:10.3390/pathogens14100970.
[6] Mazuz ML, Leibovitz B, Savitsky I, et al. The Effect of Vaccination with Neospora caninum Live-Frozen Tachyzoites on Abortion Rates of Naturally Infected Pregnant Cows. Vaccines. 2021;9(4):401. doi:10.3390/vaccines9040401.
[7] Páez L, Parra A, Sotelo E, et al. Large-scale randomized double-blind field clinical trial for safety and efficacy assessment of the DNA vaccine Neoleish against canine leishmaniasis. PLoS Negl Trop Dis. 2025;19(11):e0012707. doi:10.1371/journal.pntd.0012707.
[8] Wilson-Welder JH, Torres MP, Kipper MJ, Mallapragada SK, Wannemuehler MJ, Narasimhan B. Vaccine adjuvants: Current challenges and future approaches. J Pharm Sci. 2009;98(4):1278-1316. doi:10.1002/jps.21523.
[9] Zafar A, Arshad R, Ur Rehman A, Ahmed N, Akhtar H. Recent Developments in Oral Delivery of Vaccines Using Nanocarriers. Vaccines. 2023;11(2):490. doi:10.3390/vaccines11020490.
[10] Patra G, Kumar A, Ghosh S, Lalnunpuia C, Bachan M, Saikia B, et al. Vaccines against protozoan parasites of veterinary importance: A review. J Entomol Zool Stud. 2017;5(6):1016-1021.
[11] Wright IG, editor. Veterinary protozoan and hemoparasite vaccines. Boca Raton: CRC Press; 1989.
[12] Jenkins MC. Advances and prospects for subunit vaccines against protozoa of veterinary importance. Vet Parasitol. 2001;101(3-4):291-310. doi:10.1016/S0304-4017(01)00557-X.
[13] McAllister MM. Successful vaccines for naturally occurring protozoal diseases of animals should guide human vaccine research. A review of protozoal vaccines and their designs. Parasitology. 2014;141(5):624-640. doi:10.1017/S0031182013002060.
[14] Pereira SH, Alves FP, Teixeira SMR. Animal Trypanosomiasis: Challenges and Prospects for New Vaccination Strategies. Microorganisms. 2024;12(12):2575. doi:10.3390/microorganisms12122575.
[15] Xiao YP, Al-Khedery B, Allred DR. The Babesia bovis VESA1 virulence factor subunit 1b is encoded by the 1β branch of the ves multigene family. Mol Biochem Parasitol. 2010;171(2):81-8. doi:10.1016/j.molbiopara.2010.03.001.